Friday, March 22, 2013 4:31 PM
|
CCSVI in Multiple Sclerosis
Let's hope BNAC is monitoring the thalamus in those treated with venoplasty for CCSVI. Venoplasty reversed atrophy in my husband's gray matter structures. This is a true biomarker for MS progression and treatment success. Multiple Sclerosis research: the thalamus moves into the spotlight - News Centerwww.buffalo.edu This 3D view shows a composite of the thalamus of healthy controls (outlined in red) and MS patients (magenta). The whole thalamus is generally smaller in MS due to atrophy, and is also shifted (as seen in blue) slightly beyond the position of the normal thalamus due to atrophy of other parts of the...
|